The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?

① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.

cls.cnJan 2 16:20

Express News | Zhengguang Co., Ltd.: plans to carry out forex hedging business with a total amount not exceeding 0.1 billion yuan.

BreakingsNov 20, 2024 18:12

Zhengguang Co., Ltd. (301092.SZ): has cumulatively repurchased 0.32% of shares.

Geelonghui November 4th | Zhengguang shares (301092.SZ) announced that as of October 31, 2024, the company repurchased 428,000 shares of the company through the Shenzhen Stock Exchange stock trading system in a centralized competitive bidding trading method, accounting for 0.32% of the current total share capital of the company. The highest fill price for the repurchase was 27.92 yuan/share, the lowest fill price was 20.60 yuan/share, and the total transaction amount was RMB 10.0017 million (excluding transaction costs).

Gelonghui FinanceNov 4, 2024 18:36

Zhengguang Co., Ltd.: Report for the third quarter of 2024

SZSIOct 30, 2024 00:00 · Announcements

Zhengguang Co., Ltd. (301092.SZ): The net income in the first three quarters was 77.3391 million yuan, a year-on-year decrease of 8.50%.

GLENOHHI Oct 29th丨Competitor Lighting Co., Ltd. (301092.SZ) released the third quarter report of 2024, with revenue of 0.417 billion yuan in the first three quarters of 2024, a year-on-year increase of 6.48%; net income attributable to shareholders of the listed company was 77.3391 million yuan, a year-on-year decrease of 8.50%; net income after deducting non-recurring gains and losses was 63.4954 million yuan, a year-on-year decrease of 15.89%; basic earnings per share was 0.58 yuan per share.

Gelonghui FinanceOct 29, 2024 21:16

Zhengguang Corporation (301092.SZ) announced its performance for the first three quarters, with net income of 77.3391 million yuan, a decrease of 8.50%.

Zhengguang Co., Ltd. (301092.SZ) released the third quarter report of 2024, with the company's revenue for the first three quarters reaching 4...

Zhitong FinanceOct 29, 2024 19:56